Literature DB >> 16864839

Subtle cognitive dysfunction in adult onset myotonic dystrophy type 1 (DM1) and type 2 (DM2).

C Gaul1, T Schmidt, G Windisch, T Wieser, T Müller, S Vielhaber, S Zierz, B Leplow.   

Abstract

The authors performed neuropsychological testing in 21 patients with myotonic dystrophy type 1 (DM1) and 21 with type 2 (DM2) and healthy controls. They detected no general cognitive deficit in either DM1 or DM2, but compared to controls, both groups of patients were inferior in tests of prefrontal functioning. Patient groups did not differ in any measure. Mood status was not related to neuropsychological performance. This is consistent with findings of executive dysfunction in both DM1 and DM2.

Entities:  

Mesh:

Year:  2006        PMID: 16864839     DOI: 10.1212/01.wnl.0000225180.27833.c1

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  18 in total

1.  Cerebral and muscle MRI abnormalities in myotonic dystrophy.

Authors:  Daniel T Franc; Ryan L Muetzel; Paul R Robinson; Craig P Rodriguez; Joline C Dalton; Cameron E Naughton; Bryon A Mueller; Jeffrey R Wozniak; Kelvin O Lim; John W Day
Journal:  Neuromuscul Disord       Date:  2012-01-30       Impact factor: 4.296

2.  Diagnostic odyssey of patients with myotonic dystrophy.

Authors:  James E Hilbert; Tetsuo Ashizawa; John W Day; Elizabeth A Luebbe; William B Martens; Michael P McDermott; Rabi Tawil; Charles A Thornton; Richard T Moxley
Journal:  J Neurol       Date:  2013-06-27       Impact factor: 4.849

Review 3.  Physical inactivity and cognitive functioning: results from bed rest studies.

Authors:  Darren M Lipnicki; Hanns-Christian Gunga
Journal:  Eur J Appl Physiol       Date:  2008-09-17       Impact factor: 3.078

4.  Tractography reveals diffuse white matter abnormalities in Myotonic Dystrophy Type 1.

Authors:  Jeffrey R Wozniak; Bryon A Mueller; Kelvin O Lim; Laura S Hemmy; John W Day
Journal:  J Neurol Sci       Date:  2014-04-13       Impact factor: 3.181

5.  Frontostriatal dysexecutive syndrome: a core cognitive feature of myotonic dystrophy type 2.

Authors:  Stojan Peric; Gorana Mandic-Stojmenovic; Elka Stefanova; Dusanka Savic-Pavicevic; Jovan Pesovic; Vera Ilic; Valerija Dobricic; Ivana Basta; Dragana Lavrnic; Vidosava Rakocevic-Stojanovic
Journal:  J Neurol       Date:  2014-10-28       Impact factor: 4.849

6.  Clusters of cognitive impairment among different phenotypes of myotonic dystrophy type 1 and type 2.

Authors:  Stojan Peric; Vidosava Rakocevic Stojanovic; Gorana Mandic Stojmenovic; Vera Ilic; Masa Kovacevic; Aleksandra Parojcic; Jovan Pesovic; Milija Mijajlovic; Dusanka Savic-Pavicevic; Giovanni Meola
Journal:  Neurol Sci       Date:  2016-11-28       Impact factor: 3.307

7.  White matter abnormalities and neurocognitive correlates in children and adolescents with myotonic dystrophy type 1: a diffusion tensor imaging study.

Authors:  Jeffrey R Wozniak; Bryon A Mueller; Erin E Ward; Kelvin O Lim; John W Day
Journal:  Neuromuscul Disord       Date:  2010-12-18       Impact factor: 4.296

8.  Myotonic dystrophy CTG expansion affects synaptic vesicle proteins, neurotransmission and mouse behaviour.

Authors:  Oscar Hernández-Hernández; Céline Guiraud-Dogan; Géraldine Sicot; Aline Huguet; Sabrina Luilier; Esther Steidl; Stefanie Saenger; Elodie Marciniak; Hélène Obriot; Caroline Chevarin; Annie Nicole; Lucile Revillod; Konstantinos Charizanis; Kuang-Yung Lee; Yasuhiro Suzuki; Takashi Kimura; Tohru Matsuura; Bulmaro Cisneros; Maurice S Swanson; Fabrice Trovero; Bruno Buisson; Jean-Charles Bizot; Michel Hamon; Sandrine Humez; Guillaume Bassez; Friedrich Metzger; Luc Buée; Arnold Munnich; Nicolas Sergeant; Geneviève Gourdon; Mário Gomes-Pereira
Journal:  Brain       Date:  2013-02-11       Impact factor: 13.501

9.  Encoding of facial expressions in individuals with adult-onset myotonic dystrophy type 1.

Authors:  Claire Johnson; Kathleen E Langbehn; Jeffrey D Long; David Moser; Stephen Cross; Laurie Gutmann; Peggy C Nopoulos; Ellen van der Plas
Journal:  J Clin Exp Neuropsychol       Date:  2020-10-07       Impact factor: 2.475

10.  Patient-Reported Impact of Symptoms in Myotonic Dystrophy Type 2 (PRISM-2).

Authors:  Chad Heatwole; Nicholas Johnson; Rita Bode; Jeanne Dekdebrun; Nuran Dilek; James E Hilbert; Elizabeth Luebbe; William Martens; Michael P McDermott; Christine Quinn; Nan Rothrock; Charles Thornton; Barbara G Vickrey; David Victorson; Richard T Moxley
Journal:  Neurology       Date:  2015-11-18       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.